CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
61.67
+1.35 (2.24%)
At close: Sep 26, 2025, 4:00 PM EDT
61.36
-0.31 (-0.50%)
After-hours: Sep 26, 2025, 7:59 PM EDT
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $5.61 billion as of September 26, 2025. Its market cap has increased by 44.93% in one year.
Market Cap
5.61B
Enterprise Value
4.10B
1-Year Change
44.93%
Ranking
Category
Stock Price
$61.67
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $5.61B, an increase of 901.41%. That is a compound annual growth rate of 29.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 5.61B | 66.96% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |